EUDA Days Of Sales Outstanding from 2010 to 2024

EUDA Stock   4.43  0.11  2.55%   
EUDA Health's Days Of Sales Outstanding is decreasing over the years with slightly volatile fluctuation. Days Of Sales Outstanding is expected to dwindle to 22.38. From 2010 to 2024 EUDA Health Days Of Sales Outstanding quarterly data regression line had arithmetic mean of  61.67 and r-squared of  0.09. View All Fundamentals
 
Days Of Sales Outstanding  
First Reported
2010-12-31
Previous Quarter
23.55416546
Current Value
22.38
Quarterly Volatility
29.98961349
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check EUDA Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among EUDA Health's main balance sheet or income statement drivers, such as Tax Provision of 0.0, Depreciation And Amortization of 183.4 K or Interest Expense of 22.1 K, as well as many indicators such as Price To Sales Ratio of 11.37, Dividend Yield of 0.0 or Days Sales Outstanding of 22.38. EUDA financial statements analysis is a perfect complement when working with EUDA Health Valuation or Volatility modules.
  
Check out the analysis of EUDA Health Correlation against competitors.

Latest EUDA Health's Days Of Sales Outstanding Growth Pattern

Below is the plot of the Days Of Sales Outstanding of EUDA Health Holdings over the last few years. It is EUDA Health's Days Of Sales Outstanding historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in EUDA Health's overall financial position and show how it may be relating to other accounts over time.
Days Of Sales Outstanding10 Years Trend
Slightly volatile
   Days Of Sales Outstanding   
       Timeline  

EUDA Days Of Sales Outstanding Regression Statistics

Arithmetic Mean61.67
Geometric Mean52.25
Coefficient Of Variation48.63
Mean Deviation17.59
Median66.41
Standard Deviation29.99
Sample Variance899.38
Range134
R-Value(0.30)
Mean Square Error882.06
R-Squared0.09
Significance0.28
Slope(2.00)
Total Sum of Squares12,591

EUDA Days Of Sales Outstanding History

2024 22.38
2023 23.55
2022 7.15
2021 141.52

About EUDA Health Financial Statements

EUDA Health stakeholders use historical fundamental indicators, such as EUDA Health's Days Of Sales Outstanding, to determine how well the company is positioned to perform in the future. Although EUDA Health investors may analyze each financial statement separately, they are all interrelated. For example, changes in EUDA Health's assets and liabilities are reflected in the revenues and expenses on EUDA Health's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in EUDA Health Holdings. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Days Of Sales Outstanding 23.55  22.38 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether EUDA Health Holdings is a strong investment it is important to analyze EUDA Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact EUDA Health's future performance. For an informed investment choice regarding EUDA Stock, refer to the following important reports:
Check out the analysis of EUDA Health Correlation against competitors.
You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of EUDA Health. If investors know EUDA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about EUDA Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.62)
Revenue Per Share
0.144
Quarterly Revenue Growth
(0.14)
Return On Assets
(0.86)
The market value of EUDA Health Holdings is measured differently than its book value, which is the value of EUDA that is recorded on the company's balance sheet. Investors also form their own opinion of EUDA Health's value that differs from its market value or its book value, called intrinsic value, which is EUDA Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because EUDA Health's market value can be influenced by many factors that don't directly affect EUDA Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between EUDA Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if EUDA Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, EUDA Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.